APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anti-inflammatory Medicine for Pets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Anti-inflammatory Medicine for Pets Market Analysis and Forecast 2026-2032

Report ID 173965110221 December 2025194 pages

Choose your research edition.

Industry ResearchAnti-inflammatory Medicine for Pets Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-inflammatory Medicine for Pets Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Anti-inflammatory Medicine for Pets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-inflammatory Medicine for Pets Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-inflammatory Medicine for Pets Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Anti-inflammatory Medicine for Pets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Anti-inflammatory Medicine for Pets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Anti-inflammatory Medicine for Pets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Anti-inflammatory Medicine for Pets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Anti-inflammatory Medicine for Pets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Anti-inflammatory Medicine for Pets include Zoetis, Merck, Wuhan chopperlvya, Virbac, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun and Elanco, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Anti-inflammatory Medicine for Pets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Anti-inflammatory Medicine for Pets, also provides the sales of main regions and countries. Of the upcoming market potential for Anti-inflammatory Medicine for Pets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-inflammatory Medicine for Pets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anti-inflammatory Medicine for Pets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Anti-inflammatory Medicine for Pets sales, projected growth trends, production technology, application and end-user industry.

Anti-inflammatory Medicine for Pets Segment by Company

Zoetis

Merck

Wuhan chopperlvya

Virbac

Vetoquinol

Ouro Fino Saude

Norbrook

Jindun

Elanco

Dechra Veterinary Products

Ceva

CAHIC

Boehringer Ingelheim

Anti-inflammatory Medicine for Pets Segment by Type

Powder

Liquid

Anti-inflammatory Medicine for Pets Segment by Application

Reptile

Cat

Dog

Other

Anti-inflammatory Medicine for Pets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-inflammatory Medicine for Pets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-inflammatory Medicine for Pets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-inflammatory Medicine for Pets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Anti-inflammatory Medicine for Pets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Anti-inflammatory Medicine for Pets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-inflammatory Medicine for Pets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anti-inflammatory Medicine for Pets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Powder Major Manufacturers Table 3. Liquid Major Manufacturers Table 4. Global Anti-inflammatory Medicine for Pets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Reptile Major Manufacturers Table 6. Cat Major Manufacturers Table 7. Dog Major Manufacturers Table 8. Other Major Manufacturers Table 9. Anti-inflammatory Medicine for Pets Industry Trends Table 10. Anti-inflammatory Medicine for Pets Industry Drivers Table 11. Anti-inflammatory Medicine for Pets Industry Opportunities and Challenges Table 12. Anti-inflammatory Medicine for Pets Industry Restraints Table 13. Global Anti-inflammatory Medicine for Pets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Anti-inflammatory Medicine for Pets Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Anti-inflammatory Medicine for Pets Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Region (2021-2026) Table 17. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Region (2027-2032) Table 18. Global Anti-inflammatory Medicine for Pets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Anti-inflammatory Medicine for Pets Sales by Region (2021-2026) & (k units) Table 20. Global Anti-inflammatory Medicine for Pets Sales by Region (2027-2032) & (k units) Table 21. Global Anti-inflammatory Medicine for Pets Sales Market Share by Region (2021-2026) Table 22. Global Anti-inflammatory Medicine for Pets Sales Market Share by Region (2027-2032) Table 23. Global Anti-inflammatory Medicine for Pets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Anti-inflammatory Medicine for Pets Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Anti-inflammatory Medicine for Pets Sales Market Share by Manufacturers (2021-2026) Table 27. Global Anti-inflammatory Medicine for Pets Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Anti-inflammatory Medicine for Pets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Anti-inflammatory Medicine for Pets Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Anti-inflammatory Medicine for Pets Manufacturers, Product Type & Application Table 31. Global Anti-inflammatory Medicine for Pets Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Anti-inflammatory Medicine for Pets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Anti-inflammatory Medicine for Pets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Anti-inflammatory Medicine for Pets Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Anti-inflammatory Medicine for Pets Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Type (2021-2026) Table 38. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Type (2027-2032) Table 39. Global Anti-inflammatory Medicine for Pets Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Anti-inflammatory Medicine for Pets Sales by Type (2021-2026) & (k units) Table 41. Global Anti-inflammatory Medicine for Pets Sales by Type (2027-2032) & (k units) Table 42. Global Anti-inflammatory Medicine for Pets Sales Market Share by Type (2021-2026) Table 43. Global Anti-inflammatory Medicine for Pets Sales Market Share by Type (2027-2032) Table 44. Global Anti-inflammatory Medicine for Pets Price by Type (2021-2026) & (US$/unit) Table 45. Global Anti-inflammatory Medicine for Pets Price by Type (2027-2032) & (US$/unit) Table 46. Global Anti-inflammatory Medicine for Pets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Anti-inflammatory Medicine for Pets Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Anti-inflammatory Medicine for Pets Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Application (2021-2026) Table 50. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Application (2027-2032) Table 51. Global Anti-inflammatory Medicine for Pets Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Anti-inflammatory Medicine for Pets Sales by Application (2021-2026) & (k units) Table 53. Global Anti-inflammatory Medicine for Pets Sales by Application (2027-2032) & (k units) Table 54. Global Anti-inflammatory Medicine for Pets Sales Market Share by Application (2021-2026) Table 55. Global Anti-inflammatory Medicine for Pets Sales Market Share by Application (2027-2032) Table 56. Global Anti-inflammatory Medicine for Pets Price by Application (2021-2026) & (US$/unit) Table 57. Global Anti-inflammatory Medicine for Pets Price by Application (2027-2032) & (US$/unit) Table 58. Zoetis Company Information Table 59. Zoetis Business Overview Table 60. Zoetis Anti-inflammatory Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Zoetis Anti-inflammatory Medicine for Pets Product Portfolio Table 62. Zoetis Recent Development Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Anti-inflammatory Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Merck Anti-inflammatory Medicine for Pets Product Portfolio Table 67. Merck Recent Development Table 68. Wuhan chopperlvya Company Information Table 69. Wuhan chopperlvya Business Overview Table 70. Wuhan chopperlvya Anti-inflammatory Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Wuhan chopperlvya Anti-inflammatory Medicine for Pets Product Portfolio Table 72. Wuhan chopperlvya Recent Development Table 73. Virbac Company Information Table 74. Virbac Business Overview Table 75. Virbac Anti-inflammatory Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Virbac Anti-inflammatory Medicine for Pets Product Portfolio Table 77. Virbac Recent Development Table 78. Vetoquinol Company Information Table 79. Vetoquinol Business Overview Table 80. Vetoquinol Anti-inflammatory Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Vetoquinol Anti-inflammatory Medicine for Pets Product Portfolio Table 82. Vetoquinol Recent Development Table 83. Ouro Fino Saude Company Information Table 84. Ouro Fino Saude Business Overview Table 85. Ouro Fino Saude Anti-inflammatory Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Ouro Fino Saude Anti-inflammatory Medicine for Pets Product Portfolio Table 87. Ouro Fino Saude Recent Development Table 88. Norbrook Company Information Table 89. Norbrook Business Overview Table 90. Norbrook Anti-inflammatory Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Norbrook Anti-inflammatory Medicine for Pets Product Portfolio Table 92. Norbrook Recent Development Table 93. Jindun Company Information Table 94. Jindun Business Overview Table 95. Jindun Anti-inflammatory Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Jindun Anti-inflammatory Medicine for Pets Product Portfolio Table 97. Jindun Recent Development Table 98. Elanco Company Information Table 99. Elanco Business Overview Table 100. Elanco Anti-inflammatory Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Elanco Anti-inflammatory Medicine for Pets Product Portfolio Table 102. Elanco Recent Development Table 103. Dechra Veterinary Products Company Information Table 104. Dechra Veterinary Products Business Overview Table 105. Dechra Veterinary Products Anti-inflammatory Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Dechra Veterinary Products Anti-inflammatory Medicine for Pets Product Portfolio Table 107. Dechra Veterinary Products Recent Development Table 108. Ceva Company Information Table 109. Ceva Business Overview Table 110. Ceva Anti-inflammatory Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Ceva Anti-inflammatory Medicine for Pets Product Portfolio Table 112. Ceva Recent Development Table 113. CAHIC Company Information Table 114. CAHIC Business Overview Table 115. CAHIC Anti-inflammatory Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. CAHIC Anti-inflammatory Medicine for Pets Product Portfolio Table 117. CAHIC Recent Development Table 118. Boehringer Ingelheim Company Information Table 119. Boehringer Ingelheim Business Overview Table 120. Boehringer Ingelheim Anti-inflammatory Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Boehringer Ingelheim Anti-inflammatory Medicine for Pets Product Portfolio Table 122. Boehringer Ingelheim Recent Development Table 123. North America Anti-inflammatory Medicine for Pets Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Anti-inflammatory Medicine for Pets Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Anti-inflammatory Medicine for Pets Sales by Type (2021-2026) & (k units) Table 126. North America Anti-inflammatory Medicine for Pets Sales by Type (2027-2032) & (k units) Table 127. North America Anti-inflammatory Medicine for Pets Sales Price by Type (2021-2026) & (US$/unit) Table 128. North America Anti-inflammatory Medicine for Pets Sales Price by Type (2027-2032) & (US$/unit) Table 129. North America Anti-inflammatory Medicine for Pets Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Anti-inflammatory Medicine for Pets Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Anti-inflammatory Medicine for Pets Sales by Application (2021-2026) & (k units) Table 132. North America Anti-inflammatory Medicine for Pets Sales by Application (2027-2032) & (k units) Table 133. North America Anti-inflammatory Medicine for Pets Sales Price by Application (2021-2026) & (US$/unit) Table 134. North America Anti-inflammatory Medicine for Pets Sales Price by Application (2027-2032) & (US$/unit) Table 135. North America Anti-inflammatory Medicine for Pets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Anti-inflammatory Medicine for Pets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America Anti-inflammatory Medicine for Pets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America Anti-inflammatory Medicine for Pets Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 139. North America Anti-inflammatory Medicine for Pets Sales by Country (2021-2026) & (k units) Table 140. North America Anti-inflammatory Medicine for Pets Sales by Country (2027-2032) & (k units) Table 141. North America Anti-inflammatory Medicine for Pets Sales Price by Country (2021-2026) & (US$/unit) Table 142. North America Anti-inflammatory Medicine for Pets Sales Price by Country (2027-2032) & (US$/unit) Table 143. United States Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 144. Canada Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 145. Mexico Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 146. Europe Anti-inflammatory Medicine for Pets Revenue by Type (2021-2026) & (US$ Million) Table 147. Europe Anti-inflammatory Medicine for Pets Revenue by Type (2027-2032) & (US$ Million) Table 148. Europe Anti-inflammatory Medicine for Pets Sales by Type (2021-2026) & (k units) Table 149. Europe Anti-inflammatory Medicine for Pets Sales by Type (2027-2032) & (k units) Table 150. Europe Anti-inflammatory Medicine for Pets Sales Price by Type (2021-2026) & (US$/unit) Table 151. Europe Anti-inflammatory Medicine for Pets Sales Price by Type (2027-2032) & (US$/unit) Table 152. Europe Anti-inflammatory Medicine for Pets Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe Anti-inflammatory Medicine for Pets Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe Anti-inflammatory Medicine for Pets Sales by Application (2021-2026) & (k units) Table 155. Europe Anti-inflammatory Medicine for Pets Sales by Application (2027-2032) & (k units) Table 156. Europe Anti-inflammatory Medicine for Pets Sales Price by Application (2021-2026) & (US$/unit) Table 157. Europe Anti-inflammatory Medicine for Pets Sales Price by Application (2027-2032) & (US$/unit) Table 158. Europe Anti-inflammatory Medicine for Pets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Europe Anti-inflammatory Medicine for Pets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Europe Anti-inflammatory Medicine for Pets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Europe Anti-inflammatory Medicine for Pets Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 162. Europe Anti-inflammatory Medicine for Pets Sales by Country (2021-2026) & (k units) Table 163. Europe Anti-inflammatory Medicine for Pets Sales by Country (2027-2032) & (k units) Table 164. Europe Anti-inflammatory Medicine for Pets Sales Price by Country (2021-2026) & (US$/unit) Table 165. Europe Anti-inflammatory Medicine for Pets Sales Price by Country (2027-2032) & (US$/unit) Table 166. Germany Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 167. France Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 168. U.K. Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 169. Italy Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 170. Russia Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 171. Spain Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 172. Netherlands Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 173. Switzerland Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 174. Sweden Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 175. Poland Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 176. China Anti-inflammatory Medicine for Pets Revenue by Type (2021-2026) & (US$ Million) Table 177. China Anti-inflammatory Medicine for Pets Revenue by Type (2027-2032) & (US$ Million) Table 178. China Anti-inflammatory Medicine for Pets Sales by Type (2021-2026) & (k units) Table 179. China Anti-inflammatory Medicine for Pets Sales by Type (2027-2032) & (k units) Table 180. China Anti-inflammatory Medicine for Pets Sales Price by Type (2021-2026) & (US$/unit) Table 181. China Anti-inflammatory Medicine for Pets Sales Price by Type (2027-2032) & (US$/unit) Table 182. China Anti-inflammatory Medicine for Pets Revenue by Application (2021-2026) & (US$ Million) Table 183. China Anti-inflammatory Medicine for Pets Revenue by Application (2027-2032) & (US$ Million) Table 184. China Anti-inflammatory Medicine for Pets Sales by Application (2021-2026) & (k units) Table 185. China Anti-inflammatory Medicine for Pets Sales by Application (2027-2032) & (k units) Table 186. China Anti-inflammatory Medicine for Pets Sales Price by Application (2021-2026) & (US$/unit) Table 187. China Anti-inflammatory Medicine for Pets Sales Price by Application (2027-2032) & (US$/unit) Table 188. Asia Anti-inflammatory Medicine for Pets Revenue by Type (2021-2026) & (US$ Million) Table 189. Asia Anti-inflammatory Medicine for Pets Revenue by Type (2027-2032) & (US$ Million) Table 190. Asia Anti-inflammatory Medicine for Pets Sales by Type (2021-2026) & (k units) Table 191. Asia Anti-inflammatory Medicine for Pets Sales by Type (2027-2032) & (k units) Table 192. Asia Anti-inflammatory Medicine for Pets Sales Price by Type (2021-2026) & (US$/unit) Table 193. Asia Anti-inflammatory Medicine for Pets Sales Price by Type (2027-2032) & (US$/unit) Table 194. Asia Anti-inflammatory Medicine for Pets Revenue by Application (2021-2026) & (US$ Million) Table 195. Asia Anti-inflammatory Medicine for Pets Revenue by Application (2027-2032) & (US$ Million) Table 196. Asia Anti-inflammatory Medicine for Pets Sales by Application (2021-2026) & (k units) Table 197. Asia Anti-inflammatory Medicine for Pets Sales by Application (2027-2032) & (k units) Table 198. Asia Anti-inflammatory Medicine for Pets Sales Price by Application (2021-2026) & (US$/unit) Table 199. Asia Anti-inflammatory Medicine for Pets Sales Price by Application (2027-2032) & (US$/unit) Table 200. Asia Anti-inflammatory Medicine for Pets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Asia Anti-inflammatory Medicine for Pets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. Asia Anti-inflammatory Medicine for Pets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. Asia Anti-inflammatory Medicine for Pets Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 204. Asia Anti-inflammatory Medicine for Pets Sales by Country (2021-2026) & (k units) Table 205. Asia Anti-inflammatory Medicine for Pets Sales by Country (2027-2032) & (k units) Table 206. Asia Anti-inflammatory Medicine for Pets Sales Price by Country (2021-2026) & (US$/unit) Table 207. Asia Anti-inflammatory Medicine for Pets Sales Price by Country (2027-2032) & (US$/unit) Table 208. Japan Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 209. South Korea Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 210. India Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 211. Australia Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 212. Taiwan Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 213. Southeast Asia Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 214. SAMEA Anti-inflammatory Medicine for Pets Revenue by Type (2021-2026) & (US$ Million) Table 215. SAMEA Anti-inflammatory Medicine for Pets Revenue by Type (2027-2032) & (US$ Million) Table 216. SAMEA Anti-inflammatory Medicine for Pets Sales by Type (2021-2026) & (k units) Table 217. SAMEA Anti-inflammatory Medicine for Pets Sales by Type (2027-2032) & (k units) Table 218. SAMEA Anti-inflammatory Medicine for Pets Sales Price by Type (2021-2026) & (US$/unit) Table 219. SAMEA Anti-inflammatory Medicine for Pets Sales Price by Type (2027-2032) & (US$/unit) Table 220. SAMEA Anti-inflammatory Medicine for Pets Revenue by Application (2021-2026) & (US$ Million) Table 221. SAMEA Anti-inflammatory Medicine for Pets Revenue by Application (2027-2032) & (US$ Million) Table 222. SAMEA Anti-inflammatory Medicine for Pets Sales by Application (2021-2026) & (k units) Table 223. SAMEA Anti-inflammatory Medicine for Pets Sales by Application (2027-2032) & (k units) Table 224. SAMEA Anti-inflammatory Medicine for Pets Sales Price by Application (2021-2026) & (US$/unit) Table 225. SAMEA Anti-inflammatory Medicine for Pets Sales Price by Application (2027-2032) & (US$/unit) Table 226. SAMEA Anti-inflammatory Medicine for Pets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. SAMEA Anti-inflammatory Medicine for Pets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 228. SAMEA Anti-inflammatory Medicine for Pets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 229. SAMEA Anti-inflammatory Medicine for Pets Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 230. SAMEA Anti-inflammatory Medicine for Pets Sales by Country (2021-2026) & (k units) Table 231. SAMEA Anti-inflammatory Medicine for Pets Sales by Country (2027-2032) & (k units) Table 232. SAMEA Anti-inflammatory Medicine for Pets Sales Price by Country (2021-2026) & (US$/unit) Table 233. SAMEA Anti-inflammatory Medicine for Pets Sales Price by Country (2027-2032) & (US$/unit) Table 234. Brazil Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 235. Argentina Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 236. Chile Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 237. Colombia Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 238. Peru Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 239. Saudi Arabia Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 240. Israel Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 241. UAE Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 242. Turkey Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 243. Iran Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 244. Egypt Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Table 245. Key Raw Materials Table 246. Raw Materials Key Suppliers Table 247. Anti-inflammatory Medicine for Pets Distributors List Table 248. Anti-inflammatory Medicine for Pets Customers List Table 249. Research Programs/Design for This Report Table 250. Authors List of This Report Table 251. Secondary Sources Table 252. Primary Sources List of Figures Figure 1. Anti-inflammatory Medicine for Pets Image Figure 2. Global Anti-inflammatory Medicine for Pets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-inflammatory Medicine for Pets Market Size Share 2021 VS 2025 VS 2032 Figure 4. Powder Image Figure 5. Liquid Image Figure 6. Global Anti-inflammatory Medicine for Pets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Anti-inflammatory Medicine for Pets Market Size Share 2021 VS 2025 VS 2032 Figure 8. Reptile Image Figure 9. Cat Image Figure 10. Dog Image Figure 11. Other Image Figure 12. Global Anti-inflammatory Medicine for Pets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Figure 14. Global Anti-inflammatory Medicine for Pets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Region (2021-2032) Figure 17. Global Anti-inflammatory Medicine for Pets Sales (2021-2032) & (k units) Figure 18. Global Anti-inflammatory Medicine for Pets Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Anti-inflammatory Medicine for Pets Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Anti-inflammatory Medicine for Pets Sales YoY (2021-2032) & (k units) Figure 21. Europe Anti-inflammatory Medicine for Pets Sales YoY (2021-2032) & (k units) Figure 22. China Anti-inflammatory Medicine for Pets Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Anti-inflammatory Medicine for Pets Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Anti-inflammatory Medicine for Pets Sales YoY (2021-2032) & (k units) Figure 25. Global Anti-inflammatory Medicine for Pets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Anti-inflammatory Medicine for Pets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Anti-inflammatory Medicine for Pets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Type (2021-2032) Figure 31. Global Anti-inflammatory Medicine for Pets Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Anti-inflammatory Medicine for Pets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Anti-inflammatory Medicine for Pets Sales Market Share by Type (2021-2032) Figure 34. Global Anti-inflammatory Medicine for Pets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Application (2021-2032) Figure 37. Global Anti-inflammatory Medicine for Pets Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Anti-inflammatory Medicine for Pets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Anti-inflammatory Medicine for Pets Sales Market Share by Application (2021-2032) Figure 40. North America Anti-inflammatory Medicine for Pets Revenue Share by Type (2021-2032) Figure 41. North America Anti-inflammatory Medicine for Pets Sales Share by Type (2021-2032) Figure 42. North America Anti-inflammatory Medicine for Pets Revenue Share by Application (2021-2032) Figure 43. North America Anti-inflammatory Medicine for Pets Sales Share by Application (2021-2032) Figure 44. North America Anti-inflammatory Medicine for Pets Revenue Share by Country (2021-2032) Figure 45. North America Anti-inflammatory Medicine for Pets Sales Share by Country (2021-2032) Figure 46. Europe Anti-inflammatory Medicine for Pets Revenue Share by Type (2021-2032) Figure 47. Europe Anti-inflammatory Medicine for Pets Sales Share by Type (2021-2032) Figure 48. Europe Anti-inflammatory Medicine for Pets Revenue Share by Application (2021-2032) Figure 49. Europe Anti-inflammatory Medicine for Pets Sales Share by Application (2021-2032) Figure 50. Europe Anti-inflammatory Medicine for Pets Revenue Share by Country (2021-2032) Figure 51. Europe Anti-inflammatory Medicine for Pets Sales Share by Country (2021-2032) Figure 52. China Anti-inflammatory Medicine for Pets Revenue Share by Type (2021-2032) Figure 53. China Anti-inflammatory Medicine for Pets Sales Share by Type (2021-2032) Figure 54. China Anti-inflammatory Medicine for Pets Revenue Share by Application (2021-2032) Figure 55. China Anti-inflammatory Medicine for Pets Sales Share by Application (2021-2032) Figure 56. Asia Anti-inflammatory Medicine for Pets Revenue Share by Type (2021-2032) Figure 57. Asia Anti-inflammatory Medicine for Pets Sales Share by Type (2021-2032) Figure 58. Asia Anti-inflammatory Medicine for Pets Revenue Share by Application (2021-2032) Figure 59. Asia Anti-inflammatory Medicine for Pets Sales Share by Application (2021-2032) Figure 60. Asia Anti-inflammatory Medicine for Pets Revenue Share by Country (2021-2032) Figure 61. Asia Anti-inflammatory Medicine for Pets Sales Share by Country (2021-2032) Figure 62. SAMEA Anti-inflammatory Medicine for Pets Revenue Share by Type (2021-2032) Figure 63. SAMEA Anti-inflammatory Medicine for Pets Sales Share by Type (2021-2032) Figure 64. SAMEA Anti-inflammatory Medicine for Pets Revenue Share by Application (2021-2032) Figure 65. SAMEA Anti-inflammatory Medicine for Pets Sales Share by Application (2021-2032) Figure 66. SAMEA Anti-inflammatory Medicine for Pets Revenue Share by Country (2021-2032) Figure 67. SAMEA Anti-inflammatory Medicine for Pets Sales Share by Country (2021-2032) Figure 68. Anti-inflammatory Medicine for Pets Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Anti-inflammatory Medicine for Pets Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Liquid
Applications
  • Reptile
  • Cat
  • Dog
  • Other
Companies covered
  • Zoetis
  • Merck
  • Wuhan chopperlvya
  • Virbac
  • Vetoquinol
  • Ouro Fino Saude
  • Norbrook
  • Jindun
  • Elanco
  • Dechra Veterinary Products
  • Ceva
  • CAHIC
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Anti-inflammatory Medicine for Pets Market by Type
  3. 1.2.1 Global Anti-inflammatory Medicine for Pets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Powder
  5. 1.2.3 Liquid
  6. 1.3 Anti-inflammatory Medicine for Pets Market by Application
  7. 1.3.1 Global Anti-inflammatory Medicine for Pets Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Reptile
  9. 1.3.3 Cat
  10. 1.3.4 Dog
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Anti-inflammatory Medicine for Pets Market Dynamics
  1. 2.1 Anti-inflammatory Medicine for Pets Industry Trends
  2. 2.2 Anti-inflammatory Medicine for Pets Industry Drivers
  3. 2.3 Anti-inflammatory Medicine for Pets Industry Opportunities and Challenges
  4. 2.4 Anti-inflammatory Medicine for Pets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Anti-inflammatory Medicine for Pets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Anti-inflammatory Medicine for Pets Revenue by Region
  3. 3.2.1 Global Anti-inflammatory Medicine for Pets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Anti-inflammatory Medicine for Pets Revenue by Region (2021-2026)
  5. 3.2.3 Global Anti-inflammatory Medicine for Pets Revenue by Region (2027-2032)
  6. 3.2.4 Global Anti-inflammatory Medicine for Pets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Anti-inflammatory Medicine for Pets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Anti-inflammatory Medicine for Pets Sales by Region
  9. 3.4.1 Global Anti-inflammatory Medicine for Pets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Anti-inflammatory Medicine for Pets Sales by Region (2021-2026)
  11. 3.4.3 Global Anti-inflammatory Medicine for Pets Sales by Region (2027-2032)
  12. 3.4.4 Global Anti-inflammatory Medicine for Pets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Anti-inflammatory Medicine for Pets Revenue by Manufacturers
  2. 4.1.1 Global Anti-inflammatory Medicine for Pets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Anti-inflammatory Medicine for Pets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Anti-inflammatory Medicine for Pets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Anti-inflammatory Medicine for Pets Sales by Manufacturers
  6. 4.2.1 Global Anti-inflammatory Medicine for Pets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Anti-inflammatory Medicine for Pets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Anti-inflammatory Medicine for Pets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Anti-inflammatory Medicine for Pets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Anti-inflammatory Medicine for Pets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Anti-inflammatory Medicine for Pets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Anti-inflammatory Medicine for Pets Manufacturers, Product Type & Application
  13. 4.7 Global Anti-inflammatory Medicine for Pets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Anti-inflammatory Medicine for Pets Market CR5 and HHI
  16. 4.8.2 2025 Anti-inflammatory Medicine for Pets Tier 1, Tier 2, and Tier 3
5 Anti-inflammatory Medicine for Pets Market by Type
  1. 5.1 Global Anti-inflammatory Medicine for Pets Revenue by Type
  2. 5.1.1 Global Anti-inflammatory Medicine for Pets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Anti-inflammatory Medicine for Pets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Anti-inflammatory Medicine for Pets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Anti-inflammatory Medicine for Pets Sales by Type
  6. 5.2.1 Global Anti-inflammatory Medicine for Pets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anti-inflammatory Medicine for Pets Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Anti-inflammatory Medicine for Pets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Anti-inflammatory Medicine for Pets Price by Type
6 Anti-inflammatory Medicine for Pets Market by Application
  1. 6.1 Global Anti-inflammatory Medicine for Pets Revenue by Application
  2. 6.1.1 Global Anti-inflammatory Medicine for Pets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Anti-inflammatory Medicine for Pets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Anti-inflammatory Medicine for Pets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Anti-inflammatory Medicine for Pets Sales by Application
  6. 6.2.1 Global Anti-inflammatory Medicine for Pets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Anti-inflammatory Medicine for Pets Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Anti-inflammatory Medicine for Pets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Anti-inflammatory Medicine for Pets Price by Application
7 Company Profiles
  1. 7.1 Zoetis
  2. 7.1.1 Zoetis Company Information
  3. 7.1.2 Zoetis Business Overview
  4. 7.1.3 Zoetis Anti-inflammatory Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zoetis Anti-inflammatory Medicine for Pets Product Portfolio
  6. 7.1.5 Zoetis Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Anti-inflammatory Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Anti-inflammatory Medicine for Pets Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Wuhan chopperlvya
  14. 7.3.1 Wuhan chopperlvya Company Information
  15. 7.3.2 Wuhan chopperlvya Business Overview
  16. 7.3.3 Wuhan chopperlvya Anti-inflammatory Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Wuhan chopperlvya Anti-inflammatory Medicine for Pets Product Portfolio
  18. 7.3.5 Wuhan chopperlvya Recent Developments
  19. 7.4 Virbac
  20. 7.4.1 Virbac Company Information
  21. 7.4.2 Virbac Business Overview
  22. 7.4.3 Virbac Anti-inflammatory Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Virbac Anti-inflammatory Medicine for Pets Product Portfolio
  24. 7.4.5 Virbac Recent Developments
  25. 7.5 Vetoquinol
  26. 7.5.1 Vetoquinol Company Information
  27. 7.5.2 Vetoquinol Business Overview
  28. 7.5.3 Vetoquinol Anti-inflammatory Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Vetoquinol Anti-inflammatory Medicine for Pets Product Portfolio
  30. 7.5.5 Vetoquinol Recent Developments
  31. 7.6 Ouro Fino Saude
  32. 7.6.1 Ouro Fino Saude Company Information
  33. 7.6.2 Ouro Fino Saude Business Overview
  34. 7.6.3 Ouro Fino Saude Anti-inflammatory Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Ouro Fino Saude Anti-inflammatory Medicine for Pets Product Portfolio
  36. 7.6.5 Ouro Fino Saude Recent Developments
  37. 7.7 Norbrook
  38. 7.7.1 Norbrook Company Information
  39. 7.7.2 Norbrook Business Overview
  40. 7.7.3 Norbrook Anti-inflammatory Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Norbrook Anti-inflammatory Medicine for Pets Product Portfolio
  42. 7.7.5 Norbrook Recent Developments
  43. 7.8 Jindun
  44. 7.8.1 Jindun Company Information
  45. 7.8.2 Jindun Business Overview
  46. 7.8.3 Jindun Anti-inflammatory Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Jindun Anti-inflammatory Medicine for Pets Product Portfolio
  48. 7.8.5 Jindun Recent Developments
  49. 7.9 Elanco
  50. 7.9.1 Elanco Company Information
  51. 7.9.2 Elanco Business Overview
  52. 7.9.3 Elanco Anti-inflammatory Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Elanco Anti-inflammatory Medicine for Pets Product Portfolio
  54. 7.9.5 Elanco Recent Developments
  55. 7.10 Dechra Veterinary Products
  56. 7.10.1 Dechra Veterinary Products Company Information
  57. 7.10.2 Dechra Veterinary Products Business Overview
  58. 7.10.3 Dechra Veterinary Products Anti-inflammatory Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Dechra Veterinary Products Anti-inflammatory Medicine for Pets Product Portfolio
  60. 7.10.5 Dechra Veterinary Products Recent Developments
  61. 7.11 Ceva
  62. 7.11.1 Ceva Company Information
  63. 7.11.2 Ceva Business Overview
  64. 7.11.3 Ceva Anti-inflammatory Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Ceva Anti-inflammatory Medicine for Pets Product Portfolio
  66. 7.11.5 Ceva Recent Developments
  67. 7.12 CAHIC
  68. 7.12.1 CAHIC Company Information
  69. 7.12.2 CAHIC Business Overview
  70. 7.12.3 CAHIC Anti-inflammatory Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 CAHIC Anti-inflammatory Medicine for Pets Product Portfolio
  72. 7.12.5 CAHIC Recent Developments
  73. 7.13 Boehringer Ingelheim
  74. 7.13.1 Boehringer Ingelheim Company Information
  75. 7.13.2 Boehringer Ingelheim Business Overview
  76. 7.13.3 Boehringer Ingelheim Anti-inflammatory Medicine for Pets Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Boehringer Ingelheim Anti-inflammatory Medicine for Pets Product Portfolio
  78. 7.13.5 Boehringer Ingelheim Recent Developments
8 North America
  1. 8.1 North America Anti-inflammatory Medicine for Pets Market Size by Type
  2. 8.1.1 North America Anti-inflammatory Medicine for Pets Revenue by Type (2021-2032)
  3. 8.1.2 North America Anti-inflammatory Medicine for Pets Sales by Type (2021-2032)
  4. 8.1.3 North America Anti-inflammatory Medicine for Pets Price by Type (2021-2032)
  5. 8.2 North America Anti-inflammatory Medicine for Pets Market Size by Application
  6. 8.2.1 North America Anti-inflammatory Medicine for Pets Revenue by Application (2021-2032)
  7. 8.2.2 North America Anti-inflammatory Medicine for Pets Sales by Application (2021-2032)
  8. 8.2.3 North America Anti-inflammatory Medicine for Pets Price by Application (2021-2032)
  9. 8.3 North America Anti-inflammatory Medicine for Pets Market Size by Country
  10. 8.3.1 North America Anti-inflammatory Medicine for Pets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Anti-inflammatory Medicine for Pets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Anti-inflammatory Medicine for Pets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Anti-inflammatory Medicine for Pets Market Size by Type
  2. 9.1.1 Europe Anti-inflammatory Medicine for Pets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Anti-inflammatory Medicine for Pets Sales by Type (2021-2032)
  4. 9.1.3 Europe Anti-inflammatory Medicine for Pets Price by Type (2021-2032)
  5. 9.2 Europe Anti-inflammatory Medicine for Pets Market Size by Application
  6. 9.2.1 Europe Anti-inflammatory Medicine for Pets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Anti-inflammatory Medicine for Pets Sales by Application (2021-2032)
  8. 9.2.3 Europe Anti-inflammatory Medicine for Pets Price by Application (2021-2032)
  9. 9.3 Europe Anti-inflammatory Medicine for Pets Market Size by Country
  10. 9.3.1 Europe Anti-inflammatory Medicine for Pets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Anti-inflammatory Medicine for Pets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Anti-inflammatory Medicine for Pets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Anti-inflammatory Medicine for Pets Market Size by Type
  2. 10.1.1 China Anti-inflammatory Medicine for Pets Revenue by Type (2021-2032)
  3. 10.1.2 China Anti-inflammatory Medicine for Pets Sales by Type (2021-2032)
  4. 10.1.3 China Anti-inflammatory Medicine for Pets Price by Type (2021-2032)
  5. 10.2 China Anti-inflammatory Medicine for Pets Market Size by Application
  6. 10.2.1 China Anti-inflammatory Medicine for Pets Revenue by Application (2021-2032)
  7. 10.2.2 China Anti-inflammatory Medicine for Pets Sales by Application (2021-2032)
  8. 10.2.3 China Anti-inflammatory Medicine for Pets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Anti-inflammatory Medicine for Pets Market Size by Type
  2. 11.1.1 Asia Anti-inflammatory Medicine for Pets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Anti-inflammatory Medicine for Pets Sales by Type (2021-2032)
  4. 11.1.3 Asia Anti-inflammatory Medicine for Pets Price by Type (2021-2032)
  5. 11.2 Asia Anti-inflammatory Medicine for Pets Market Size by Application
  6. 11.2.1 Asia Anti-inflammatory Medicine for Pets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Anti-inflammatory Medicine for Pets Sales by Application (2021-2032)
  8. 11.2.3 Asia Anti-inflammatory Medicine for Pets Price by Application (2021-2032)
  9. 11.3 Asia Anti-inflammatory Medicine for Pets Market Size by Country
  10. 11.3.1 Asia Anti-inflammatory Medicine for Pets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Anti-inflammatory Medicine for Pets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Anti-inflammatory Medicine for Pets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Anti-inflammatory Medicine for Pets Market Size by Type
  2. 12.1.1 SAMEA Anti-inflammatory Medicine for Pets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Anti-inflammatory Medicine for Pets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Anti-inflammatory Medicine for Pets Price by Type (2021-2032)
  5. 12.2 SAMEA Anti-inflammatory Medicine for Pets Market Size by Application
  6. 12.2.1 SAMEA Anti-inflammatory Medicine for Pets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Anti-inflammatory Medicine for Pets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Anti-inflammatory Medicine for Pets Price by Application (2021-2032)
  9. 12.3 SAMEA Anti-inflammatory Medicine for Pets Market Size by Country
  10. 12.3.1 SAMEA Anti-inflammatory Medicine for Pets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Anti-inflammatory Medicine for Pets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Anti-inflammatory Medicine for Pets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Anti-inflammatory Medicine for Pets Value Chain Analysis
  2. 13.1.1 Anti-inflammatory Medicine for Pets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Anti-inflammatory Medicine for Pets Production Mode & Process
  6. 13.2 Anti-inflammatory Medicine for Pets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Anti-inflammatory Medicine for Pets Distributors
  9. 13.2.3 Anti-inflammatory Medicine for Pets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst